Terms: = Breast cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
467 results:
1. Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer.
Rönnlund C; Sifakis EG; Schagerholm C; Yang Q; Karlsson E; Chen X; Foukakis T; Weidler J; Bates M; Fredriksson I; Robertson S; Hartman J
Breast Cancer Res; 2024 Feb; 26(1):24. PubMed ID: 38321542
[TBL] [Abstract] [Full Text] [Related]
2. Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer.
Zhong J; Jiang H; Liu X; Liao H; Xie F; Shao B; Jia S; Li H
Breast Cancer Res Treat; 2024 Apr; 204(3):617-629. PubMed ID: 38183515
[TBL] [Abstract] [Full Text] [Related]
3. Therapeutic effect and metabolic fingerprinting of triple-negative breast cancer cells following exposure to a novel pH-responsive, gambogic acid-loaded micelle.
Da M; Li S; Yang R; Jia Z; Ma Y; Qi F; Zhao J; Shen G; Chen D
Nanotechnology; 2023 Dec; 35(11):. PubMed ID: 38081078
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
Lammers SWM; Geurts SME; van Hellemond IEG; Swinkels ACP; Smorenburg CH; van der Sangen MJC; Kroep JR; de Graaf H; Honkoop AH; Erdkamp FLG; de Roos WK; Linn SC; Imholz ALT; Smidt ML; Vriens IJH; Tjan-Heijnen VCG
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37991939
[TBL] [Abstract] [Full Text] [Related]
5. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
6. Re-evaluation of publicly available gene-expression databases using machine-learning yields a maximum prognostic power in breast cancer.
Tschodu D; Lippoldt J; Gottheil P; Wegscheider AS; Käs JA; Niendorf A
Sci Rep; 2023 Oct; 13(1):16402. PubMed ID: 37798300
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of three
Dos Santos SN; Wuest M; Jans HS; Woodfield J; Nario AP; Krys D; Dufour J; Glubrecht D; Bergman C; Bernardes ES; Wuest F
Nucl Med Biol; 2023; 124-125():108383. PubMed ID: 37651917
[TBL] [Abstract] [Full Text] [Related]
8. Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary breast and Colorectal cancer Patients.
Côrtes L; Basso TR; Villacis RAR; Souza JDS; Jørgensen MMA; Achatz MI; Rogatto SR
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628631
[TBL] [Abstract] [Full Text] [Related]
9. Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study.
Kwan ML; Valice E; Ergas IJ; Roh JM; Caan BJ; Cespedes Feliciano EM; Kolevska T; Hartman TJ; Quesenberry CP; Ambrosone CB; Kushi LH
Cancer; 2023 Dec; 129(24):3938-3951. PubMed ID: 37555890
[TBL] [Abstract] [Full Text] [Related]
10. Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study.
Castro-Espin C; Bonet C; Crous-Bou M; Nadal-Zaragoza N; Tjønneland A; Mellemkjær L; Hajji-Louati M; Truong T; Katzke V; Le Cornet C; Schulze MB; Jannasch F; Masala G; Sieri S; Panico S; Di Girolamo C; Skeie G; Borch KB; Olsen KS; Sánchez MJ; Amiano P; Chirlaque MD; Guevara M; Sund M; Bodén S; Gunter MJ; Gonzalez-Gil EM; Weiderpass E; Aguilera-Buenosvinos I; Tsilidis KK; Heath AK; Aune D; Dossus L; Agudo A
BMC Med; 2023 Jun; 21(1):225. PubMed ID: 37365585
[TBL] [Abstract] [Full Text] [Related]
11. Serum Essential Elements and Survival after cancer Diagnosis.
Lubiński J; Lener MR; Marciniak W; Pietrzak S; Derkacz R; Cybulski C; Gronwald J; Dębniak T; Jakubowska A; Huzarski T; Matuszczak M; Pullella K; Sun P; Narod SA
Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299574
[TBL] [Abstract] [Full Text] [Related]
12. Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
Wang ML; Jurczak W; Zinzani PL; Eyre TA; Cheah CY; Ujjani CS; Koh Y; Izutsu K; Gerson JN; Flinn I; Tessoulin B; Alencar AJ; Ma S; Lewis D; Lech-Maranda E; Rhodes J; Patel K; Maddocks K; Lamanna N; Wang Y; Tam CS; Munir T; Nagai H; Hernandez-Ilizaliturri F; Kumar A; Fenske TS; Seymour JF; Zelenetz AD; Nair B; Tsai DE; Balbas M; Walgren RA; Abada P; Wang C; Zhao J; Mato AR; Shah NN
J Clin Oncol; 2023 Aug; 41(24):3988-3997. PubMed ID: 37192437
[TBL] [Abstract] [Full Text] [Related]
13. Survival Outcomes in Patients With Hormone Receptor-Positive Metastatic breast cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy.
Mouabbi JA; Singareeka Raghavendra A; Bassett RL; Hassan A; Tripathy D; Layman RM
JAMA Netw Open; 2023 May; 6(5):e2313017. PubMed ID: 37166793
[TBL] [Abstract] [Full Text] [Related]
14. Adherence to cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk breast cancer.
Cannioto RA; Attwood KM; Davis EW; Mendicino LA; Hutson A; Zirpoli GR; Tang L; Nair NM; Barlow W; Hershman DL; Unger JM; Moore HCF; Isaacs C; Hobday TJ; Hortobagyi GN; Gralow JR; Albain KS; Budd GT; Ambrosone CB
JAMA Netw Open; 2023 May; 6(5):e2311673. PubMed ID: 37140922
[TBL] [Abstract] [Full Text] [Related]
15. Associations of Post-Diagnosis Lifestyle with prognosis in Women with Invasive breast cancer.
Troeschel AN; Hartman TJ; McCullough LE; Ergas IJ; Collin LJ; Kwan ML; Ambrosone CB; Flanders WD; Bradshaw PT; Cespedes Feliciano EM; Roh JM; Wang Y; Valice E; Kushi LH
Cancer Epidemiol Biomarkers Prev; 2023 Jul; 32(7):963-975. PubMed ID: 37079336
[TBL] [Abstract] [Full Text] [Related]
16. Long-term Survival in breast cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study.
Ragusi MAA; van der Velden BHM; Meeuwis C; Tetteroo E; Coerkamp EG; van Nijnatten TJA; Jansen FH; Wolters-van der Ben EJM; Jongen L; van Raamt F; Dorrius MD; Verloop J; Viergever MA; Pijnappel RM; Elias SG; Gilhuijs KGA
Radiology; 2023 May; 307(4):e221922. PubMed ID: 36975820
[TBL] [Abstract] [Full Text] [Related]
17. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; ; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón Y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido Dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U; Modugno F; Pharoah PD; Schildkraut JM; Sieh W; Staebler A; Sundfeldt K; Swerdlow AJ; Ramus SJ; Brenton JD
J Pathol Clin Res; 2023 May; 9(3):208-222. PubMed ID: 36948887
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathologic Predictors of Clinical Outcomes in Mammary Adenoid Cystic Carcinoma: A Multi-institutional Study.
Khoury T; Rosa M; Nayak A; Karabakhtsian R; Fadare O; Li Z; Turner B; Fang Y; Kumarapeli A; Li X; Numbere N; Villatoro T; Wang JG; Sadeghi S; Attwood K; George A; Bhargava R
Mod Pathol; 2023 Feb; 36(2):100006. PubMed ID: 36853781
[TBL] [Abstract] [Full Text] [Related]
19. Synthesis and the In Vitro Evaluation of Antitumor Activity of Novel Thiobenzanilides.
Álvaro-Martins MJ; Railean V; Martins F; Machuqueiro M; Pacheco R; Santos S
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838864
[TBL] [Abstract] [Full Text] [Related]
20. Association of altered metabolic profiles and long non-coding RNAs expression with disease severity in breast cancer patients: analysis by
Shekher A; Puneet ; Awasthee N; Kumar U; Raj R; Kumar D; Gupta SC
Metabolomics; 2023 Jan; 19(2):8. PubMed ID: 36710275
[TBL] [Abstract] [Full Text] [Related]
[Next]
